These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 2681969)

  • 1. Endocrine and metabolic abnormalities following kidney transplantation.
    Hörl WH; Riegel W; Wanner C; Haag-Weber M; Schollmeyer P; Wieland H; Wilms H
    Klin Wochenschr; 1989 Sep; 67(17):907-18. PubMed ID: 2681969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine-metabolic pathophysiologic conditions and treatment approaches after kidney transplantation.
    Gosmanova EO; Tangpricha V; Gosmanov AR
    Endocr Pract; 2012; 18(4):579-90. PubMed ID: 22849872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
    Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN
    Nephron; 1997; 75(3):277-82. PubMed ID: 9069448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipoproteinemia in renal transplantation.
    Gunjotikar RV; Taskar SP; Almeida AF; Acharya VN
    J Postgrad Med; 1994; 40(1):10-2. PubMed ID: 8568706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transplant diabetes mellitus. The role of immunosuppression.
    Jindal RM; Sidner RA; Milgrom ML
    Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of endocrine organs in kidney transplant patients.
    Kokot F; Wiecek A
    Ann Transplant; 1996; 1(1):23-8. PubMed ID: 9869933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyclosporin A and low dosages of steroid on posttransplantation diabetes in kidney transplant recipients.
    Yamamoto H; Akazawa S; Yamaguchi Y; Yokota A; Yamasaki H; Nakanishi T; Tahara D; Matsuya F; Saito Y; Nagataki S
    Diabetes Care; 1991 Oct; 14(10):867-70. PubMed ID: 1773683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients.
    Harris KP; Russell GI; Parvin SD; Veitch PS; Walls J
    Br Med J (Clin Res Ed); 1986 Jan; 292(6512):16. PubMed ID: 3080047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidemia and transplantation: etiologic factors and therapy.
    Pirsch JD; D'Alessandro AM; Sollinger HW; Knechtle SJ; Reed A; Kalayoglu M; Belzer FO
    J Am Soc Nephrol; 1992 Jun; 2(12 Suppl):S238-42. PubMed ID: 1498281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation.
    Spinelli GA; Felipe CR; Machado PG; Garcia R; Casarini DE; Moreira SR; Park SI; Tedesco-Silva H; Medina-Pestana JO
    Braz J Med Biol Res; 2006 Jan; 39(1):19-30. PubMed ID: 16400461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein pattern in end-stage renal disease and following successful renal transplantation.
    Banyai-Falger S; Gottsauner-Wolf M; Stepan E; Strobl W; Jansen M; Heinz G; Hörl WH; Derfler K
    Clin Transplant; 1997 Dec; 11(6):545-51. PubMed ID: 9408682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effect of cyclosporin on plasma cholesterol in renal transplant recipients.
    Raine AE; Carter R; Mann JI; Morris PJ
    Nephrol Dial Transplant; 1988; 3(4):458-63. PubMed ID: 3140134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipidemia in renal transplant recipients: natural history and response to treatment.
    Ong CS; Pollock CA; Caterson RJ; Mahony JF; Waugh DA; Ibels LS
    Medicine (Baltimore); 1994 Jul; 73(4):215-23. PubMed ID: 8041244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic disorders in renal transplant recipients].
    Mikolasević I; Jelić I; Sladoje-Martinović B; Orlić L; Zivcić-Cosić S; Vuksanović-Mikulicić S; Mijić M; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):235-41. PubMed ID: 23441539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hyperlipidaemia associated with heart transplantation.
    Wenke K
    Drugs; 2004; 64(10):1053-68. PubMed ID: 15139786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlipidemia after organ transplantation.
    Markell MS; Friedman EA
    Am J Med; 1989 Nov; 87(5N):61N-67N. PubMed ID: 2486550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine alterations in kidney transplant patients.
    Kokot F; Grzeszczak W; Zukowska-Szczechowska E; Wiecek A
    Blood Purif; 1990; 8(2):76-86. PubMed ID: 2194517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of conversion from cyclosporin to azathioprine on renin-containing cells in renal allograft biopsies.
    Gardiner DS; Watson MA; Junor BJ; Briggs JD; More IA; Lindop GB
    Nephrol Dial Transplant; 1991; 6(5):363-7. PubMed ID: 1870754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.